BiotechTube
Home/Optimvia/Keith M. Kleeman
KM

Keith M. Kleeman

CEO and Chair of the Board

Optimvia

Therapeutic Areas

AnticoagulationThrombosis

Optimvia Pipeline

DrugIndicationPhase
Biosynthetic HeparinAnticoagulation/AntithrombosisPre-clinical

Leadership Team at Optimvia

JE
James E. Rothman, PhD
Director
SG
Steve Geis, PhD, MD
Director
MK
Mick Kowitz
Director
View full Optimvia profile